Traders Sell Walgreens Boots Alliance (WBA) on Strength (WBA)

Traders sold shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on strength during trading on Wednesday. $87.45 million flowed into the stock on the tick-up and $112.78 million flowed out of the stock on the tick-down, for a money net flow of $25.33 million out of the stock. Of all stocks tracked, Walgreens Boots Alliance had the 0th highest net out-flow for the day. Walgreens Boots Alliance traded up $0.56 for the day and closed at $75.51

Several research analysts have recently weighed in on the company. Needham & Company LLC lowered their target price on Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a report on Wednesday, November 22nd. Jefferies Group set a $93.00 price target on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Sunday, October 29th. Pivotal Research set a $73.00 price target on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a research report on Friday. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Finally, BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $86.05.

The company has a market capitalization of $70,910.00, a PE ratio of 19.78, a PEG ratio of 1.35 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.04. The company had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.10 earnings per share. research analysts forecast that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date was Friday, November 10th. Walgreens Boots Alliance’s payout ratio is 44.20%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share repurchase plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The stock was acquired at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of the stock. Commonwealth Bank of Australia boosted its stake in Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after acquiring an additional 26,893 shares in the last quarter. Andra AP fonden raised its holdings in shares of Walgreens Boots Alliance by 6.9% in the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after buying an additional 4,000 shares during the last quarter. IBM Retirement Fund raised its holdings in shares of Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after buying an additional 10,729 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in shares of Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after buying an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. raised its holdings in shares of Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after buying an additional 750 shares during the last quarter. Hedge funds and other institutional investors own 61.18% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Traders Sell Walgreens Boots Alliance (WBA) on Strength (WBA)” was originally reported by Ticker Report and is owned by of Ticker Report. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/3126834/traders-sell-walgreens-boots-alliance-wba-on-strength-wba-2.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2018 Ticker Report. Google+.